Advertisement

Surgery pp 1925-1932 | Cite as

Fundamentals of Cancer Genomics and Proteomics

  • Jimmy C. Sung
  • Alice Y. Lee
  • Timothy J. Yeatman

Abstract

The foundation of modern surgery has long been based on a clear understanding of anatomy and physiology. This structural and functional paradigm has produced tremendous progress in the comprehension and treatment of human disease. The advent of molecular biology and the completion of the Human Genome Project, however, have brought forth a new scientific basis for surgical investigation and practice. In the era of genomic medicine, molecular structures and gene functions are the foundation for the conceptualization of surgical diseases. Because genetic mutation is the basis for the abnormal phenotypic presentation in tumors, surgical oncology is an excellent field in which to translate the discoveries of genomic research into novel therapeutic approaches. The aim of this chapter is to provide a primer for oncologists and surgeons to understand the relevance and applications of genomics and proteomics in surgical oncology.

Keywords

Support Vector Machine Gene Expression Profile Genomic Medicine Class Discovery Gene Expression Monitoring 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yeatman TJ. The future of cancer management: translating the genome, transcriptome, and proteome. Ann Surg Oncol 2003;10(1):7–14.PubMedCrossRefGoogle Scholar
  2. 2.
    Lander ES, Linton LM, Birren B, et al. Intitial sequencing and analysis of the human genome. Nature (Lond) 2001;409:860–921.PubMedCrossRefGoogle Scholar
  3. 3.
    Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304–1351.PubMedCrossRefGoogle Scholar
  4. 4.
    Schena M, Shalon D, Heller R, Chai A, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467–470.PubMedCrossRefGoogle Scholar
  5. 5.
    Aebersold R, Mann, M. Mass spectrometry-based proteomics. Nature (Lond) 2003;422:198–207.PubMedCrossRefGoogle Scholar
  6. 6.
    Steen H, Mann M. The ABC’s (and XYZ’s) of peptide sequencing. Nat Rev Mol Cell Biol 2004;5:699–711.PubMedCrossRefGoogle Scholar
  7. 7.
    Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4(7):844–847.PubMedCrossRefGoogle Scholar
  8. 8.
    Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159(6):2249–2256.PubMedGoogle Scholar
  9. 9.
    Eschrich S, Yeatman TJ. DNA microarrays and data analysis: an overview. Surgery (St. Louis) 2004;136(3):500–503.PubMedCrossRefGoogle Scholar
  10. 10.
    Shimkets RA, LaRochelle WJ. The Oncogenomics Handbook: Understanding and Treating Cancer in the 21st Century. Totowa, NJ: Humana Press, 2004.Google Scholar
  11. 11.
    Quackenbush J. Computational analysis of microarray data. Nat Rev Genet 2001;6(2):418–427.CrossRefGoogle Scholar
  12. 12.
    Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286(5439):531–537.PubMedCrossRefGoogle Scholar
  13. 13.
    Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond) 2000;403(6769):503–511.PubMedCrossRefGoogle Scholar
  14. 14.
    Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (Lond) 2000;406(6795):536–540.PubMedCrossRefGoogle Scholar
  15. 15.
    Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531–537.PubMedCrossRefGoogle Scholar
  16. 16.
    Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature (Lond) 2000;406(6797):747–752.PubMedCrossRefGoogle Scholar
  17. 17.
    van’t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond) 2002;415:530–535.CrossRefGoogle Scholar
  18. 18.
    van de Vijver MJ, He YD, van’t Veer LJ, et al. A gene-expression signatureasapredictorofsurvival.N Engl J Med 2002;347(25):1999–2009.PubMedCrossRefGoogle Scholar
  19. 19.
    Tomida S, Koshikawa K, Yatabe Y, et al. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene 2004;23(31):5360–5370.PubMedCrossRefGoogle Scholar
  20. 20.
    Lapointe J, Li C, Higgins JP, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 2004;101(3):811–816.PubMedCrossRefGoogle Scholar
  21. 21.
    Vasselli JR, Shih JH, Iyengar SR, et al. Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci USA 2003;100(12):6958–6963.PubMedCrossRefGoogle Scholar
  22. 22.
    Dave S, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004;351:2159–2169.PubMedCrossRefGoogle Scholar
  23. 23.
    Bloom G, Yang IV, Boulware D, et al. Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 2004;164(1):9–16.PubMedGoogle Scholar
  24. 24.
    Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98(24):13790–13795.PubMedCrossRefGoogle Scholar
  25. 25.
    Evans W, Relling M. Moving towards individualized medicine with pharmacogenomics. Nature (Lond) 2004;429(6990):464–468.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Jimmy C. Sung
    • 1
  • Alice Y. Lee
    • 2
  • Timothy J. Yeatman
    • 3
    • 4
  1. 1.Department of SurgeryUniversity of South FloridaTampaUSA
  2. 2.H. Lee Moffitt Cancer Center and Research InstituteTampaUSA
  3. 3.Department of Clinical InvestigationsH. Lee Moffitt Cancer Center and Research InstituteTampaUSA
  4. 4.Department of Interdisciplinary OncologyH. Lee Moffitt Cancer Center and Research InstituteTampaUSA

Personalised recommendations